You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 8, February 25, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Pregnancy and Breast Feeding
 •Pediatrics
 •Pediatrics, Other
 •Alert me on articles by topic

Magnesium Sulfate for Preterm Neuroprotection

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their study of magnesium sulfate given for neuroprotection before preterm birth, Dr Crowther and colleagues1 concluded that "combined death or substantial gross motor dysfunction was significantly reduced in the magnesium group." Although composite outcomes can compensate for the low frequency of several individual outcomes, they are thus heterogeneous and sometimes difficult to interpret. We therefore question the definition and usefulness of this composite outcome. The individual components of these composite outcomes are vastly different from one another and do not share the same economical, social, or clinical value. Thus, it is difficult for clinicians to know how to counsel patients about the benefit(s) of this intervention.

The authors concluded that "magnesium sulfate given to women immediately before very preterm birth may improve important pediatric outcomes." Perhaps a better conclusion would have been that this trial was a negative study because magnesium sulfate was not effective in . . . [Full Text of this Article]

Cande V. Ananth, PhD, MPH
cande.ananth@umdnj.edu

Anthony M. Vintzileos, MD
Department of Obstetrics, Gynecology and Reproductive Sciences
University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School
New Brunswick


RELATED ARTICLES

Magnesium Sulfate for Preterm Neuroprotection
Robert Mittendorf, Kwang-Sun Lee, Nancy J. Roizen, and Peter G. Pryde
JAMA. 2004;291(8):940-941.
EXTRACT | FULL TEXT  

Magnesium Sulfate for Preterm Neuroprotection—Reply
Caroline A. Crowther, Janet E. Hiller, Lex W. Doyle, and Ross R. Haslam
JAMA. 2004;291(8):941.
EXTRACT | FULL TEXT  

Effect of Magnesium Sulfate Given for Neuroprotection Before Preterm Birth: A Randomized Controlled Trial
Caroline A. Crowther, Janet E. Hiller, Lex W. Doyle, and Ross R. Haslam
JAMA. 2003;290(20):2669-2676.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.